Open AccessLinderalactone Suppresses Pancreatic Cancer Development In Vitro and In Vivo via Negatively Regulating PI3K/AKT Signaling Pathway
Author(s) -
Dongchao Xu,
Mengyao Tian,
Wangyang Chen,
Ying Bian,
Xiaofeng Xia,
Qiang Liu,
Liyun Zheng,
Xiaofeng Zhang,
Hongzhang Shen
Publication year - 2022
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2022/8675096
Subject(s) - pi3k/akt/mtor pathway , pancreatic cancer , protein kinase b , apoptosis , in vivo , cell cycle , cancer research , in vitro , cell growth , signal transduction , chemistry , phosphorylation , cancer , biology , microbiology and biotechnology , medicine , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom